These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31980120)

  • 1. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.
    Davis GM; Galindo RJ; Migdal AL; Umpierrez GE
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):79-93. PubMed ID: 31980123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology in Diabetes: The Future Is Today.
    Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):xv-xvi. PubMed ID: 31980126
    [No Abstract]   [Full Text] [Related]  

  • 4. Banting Memorial Lecture 2014* Technology and diabetes care: appropriate and personalized.
    Pickup JC
    Diabet Med; 2015 Jan; 32(1):3-13. PubMed ID: 25345658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and Challenges of Diabetes Technology Use in Older Adults.
    Toschi E; Munshi MN
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):57-67. PubMed ID: 31980121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Insulin Delivery in Children with Type 1 Diabetes.
    Cengiz E
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):157-166. PubMed ID: 31980115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes.
    Farrington C; Stewart ZA; Barnard K; Hovorka R; Murphy HR
    Diabet Med; 2017 Oct; 34(10):1461-1469. PubMed ID: 28631849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Diabetes Technology.
    Dovc K; Battelino T
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):1-18. PubMed ID: 31980111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.
    Umpierrez GE; Klonoff DC
    Diabetes Care; 2018 Aug; 41(8):1579-1589. PubMed ID: 29936424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technical approach to the diabetes therapy.
    Dovc K; Battelino T
    Minerva Pediatr; 2020 Aug; 72(4):263-277. PubMed ID: 32418412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy.
    Farrington C; Stewart Z; Hovorka R; Murphy H
    J Diabetes Sci Technol; 2018 Nov; 12(6):1125-1131. PubMed ID: 30288999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.